NeuroPace (NPCE) Other Non Operating Income (2020 - 2026)
NeuroPace's (NPCE) quarterly Other Non Operating Income came in at -$165000.0 in Q1 2026, down 101.22% year-on-year from $13.5 million in Q1 2025, and down 301.22% quarter-over-quarter from $82000.0 in Q3 2025.
NeuroPace (NPCE) Other Non Operating Income (2020 - 2026) Analysis & Trends
NeuroPace's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$165000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 101.22% year-over-year to -$165000.0 in Q1 2026; TTM through Mar 2026 was -$569000.0, a 432.75% decrease from a year earlier, with the FY2025 full-year figure at -$486000.0, down 259.87% from the prior year.
- Other Non Operating Income fell to -$165000.0 in Q1 2026 per NPCE's latest filing, from $82000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $265000.0 in Q4 2023 and bottomed at -$817000.0 in Q1 2023.
- The 5-year median for Other Non Operating Income is -$42500.0 (2022), against an average of -$62437.5.
- Biggest YoY gain for Other Non Operating Income was 281.51% in 2023; the steepest drop was 27133.33% in 2023.
- Year by year, Other Non Operating Income stood at -$146000.0 in 2022, then soared by 281.51% to $265000.0 in 2023, then plunged by 132.45% to -$86000.0 in 2024, then surged by 195.35% to $82000.0 in 2025, then tumbled by 301.22% to -$165000.0 in 2026.
- Per Business Quant, the three latest NPCE Other Non Operating Income figures stand at -$165000.0 (Q1 2026), $82000.0 (Q3 2025), and -$486000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -165,000.00 |
| Sep 30, 2025 | 82,000.00 |
| Jun 30, 2025 | -486,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Dec 31, 2024 | -86,000.00 |
| Sep 30, 2024 | 219,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 265,000.00 |
| Sep 30, 2023 | 115,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Mar 31, 2023 | -817,000.00 |
| Dec 31, 2022 | -146,000.00 |
| Sep 30, 2022 | -103,000.00 |
| Jun 30, 2022 | -85,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -150,000.00 |
| Jun 30, 2021 | -2.12 Mn |
| Mar 31, 2021 | -3.11 Mn |